Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin alfa for physical performance in Friedreich ataxia
2011-006156-37Phase 2Completed
- Sponsor
- University of Naples Federico II
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Friedreich ataxia (FA) comparing Epoetin alfa with Placebo (2 arms). Primary endpoint: Peak oxygen consumption at cardiopulmonary exercise testing. Started Jul 2012; status: completed.
02
Drugs
epoetin alfa
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on 2011-006156-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006156-37.